Acorda


J.P. Morgan Cuts Price Target on Acorda (ACOR) Stock Following Negative Ruling on Ampyra Patent

Did an iceberg just wallop into Acorda (ACOR) stock? The drug maker’s shares are plunging at breakneck speed of almost 22% after the U.

J.P. Morgan Says Acorda Troubling Parkinson’s Trial Lessens Upside Potential

Acorda Therapeutics Inc (NASDAQ:ACOR) shareholders are spooked right now after the drug maker confirmed yesterday that enrollment in two long-term safety trials for …